Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Multi-center, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over Study to Assess the Effect of 50µg Inhaled NVA237 on Exercise Endurance in Patients With Moderate to Severe COPD
glycopyrronium
CNVA237A2310
NCT01154127
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
 
June 2016

Powered by ideaPoint, Inc.